Treatment of volunteers or animals with endotoxin in vivo results in reduced vascular reactivity to catecholamines. Endotoxin also causes liberation of the vasoactive cytokines interleukin-1 (IL-1) and tumor necrosis factor (TNF) from vascular smooth muscle and endothelial cells in culture. This study tested whether defects in contractility could be induced in isolated vascular tissue by prolonged exposure to endotoxin (1-100 ng/ml) in vitro, and whether IL-1 and TNF release by blood vessels is altered during the establishment of endotoxininduced contractile dysfunction. A concentration of endotoxin as low as 1 ng/mI suppressed contractions to norepinephrine (NE) and KCl; aortic sensitivity to NE also decreased. The presence of serum constituents or an intact endothelium were not necessary for endotoxin-induced vascular suppression. Aortas incubated with endotoxin liberated IL-1 and TNF in a dose-dependent fashion. The addition of dexamethasone or indomethacin during the incubations generally suppressed release of the cytokines and improved tissue reactivity to NE. The endotoxin-induced diminished vascular contraction and augmented IL-1 and TNF liberation required de novo protein synthesis; tissue incubated with endotoxin plus actinomycin D was completely shielded from the influence of endotoxin on vascular reactivity to NE. The association between endotoxininduced vascular cytokine release and diminished contraction suggests a possible role for cytokines derived from the vasculature in the regulation of contractile function. (J. Clin. Invest.
Introduction
Septic patients frequently exhibit increased plasma concentrations of epinephrine and norepinephrine (NE), but show a decrease in the positive correlation that exists between catecholamine concentrations and systolic blood pressure (1) . This disordered relationship between catecholamines and vascular tone is reflected by the diminished peripheral systemic vascular resistance that frequently occurs in sepsis (2, 3) . Depressed vascular reactions to pressor agents are also present in animal models of experimental sepsis. Septic rats display diminished pressor responses to both NE and angiotensin II in vivo (4) .
The sepsis-induced decrease in vascular reactivity persists when tissue is removed from septic rats and tested with NE and vasopressin in vitro (5) .
Endotoxin is present in the circulation during sepsis and in early stages ofthe development ofthe disorder has been found to be an accurate predictor for subsequent septicemia, even more so than the documentation ofblood cultures positive for Gram-negative bacteria (6) . Increased plasma concentrations of endotoxin could contribute to the curtailed sensitivity to catecholamines by acting directly on the vasculature, by induction and/or release of circulating vasoactive mediators, or by a combination of the two actions. In volunteers, intravenous injection of 1 ,ug of Escherichia coli endotoxin results in diminution of vascular reactivity to NE 3-4 h after the injection (7) . Intravenous injection of 2 mg/kg endotoxin in cats also results, 2-3 h later, in impaired vasoconstrictor responses to NE (8) . The endotoxin-induced decrease in pressor responses persist when aortas from endotoxin-injected rats (6 mg/kg) are removed and tested in vitro (9) . It is probable, however, that intravenous injection of milligram per kilogram quantities of endotoxin results in a short-term exposure of the vasculature to endotoxin concentrations that exceed actual pathophysiological levels by at least three orders ofmagnitude. Reported levels for biologically active endotoxins in sepsis vary widely, reflecting differences in endotoxin standards, assays, diseases, and models utilized. In humans, maximal reported concentrations of endotoxin in plasma range from > 0.1 (6) , 0.85 (10) , and 5 ng/ml (11) , to as high as tens of nanograms per milliliter for lipooligosaccharides in systemic meningococcal disease (12) . Plasma endotoxin concentrations reach levels slightly > 1 ng/ml during infusion of a lethal dose of E. coli into primates (13) .
The present study was designed to investigate whether long-term exposure of rat aortic tissue to pathophysiologically relevant concentrations of endotoxin in vitro was sufficient to impart contractile defects similar to those documented in sepsis or after exposure to endotoxin in vivo. In addition, the influence of pharmacologic interventions on endotoxin-induced alteration in vascular function were investigated. Finally, because we have previously shown that IL-1 and tumor necrosis factor (TNF)' are implicated in inducing defective vascular contraction to pressor agents (5, 14, 15) , the release of these cytokines by the rat aorta in response to endotoxin and during pharmacologic intervention was monitored.
Methods
Tissue preparation and incubation. Male Sprague-Dawley rats (150-250 g, Taconic Farms, Germantown, NY) were decapitated, the thoracic aorta and associated adventitia were dissected, and four rings (3.5 mm in length) were cut from each aorta. Some aortas were deendothelialized before sectioning into rings. Aortas were deendothelialized by perfusion with phosphate-buffered saline (PBS) containing 2% sodium deoxycholate and air bubbles for 20 s, followed by a PBS and bubble rinse for 5 min. Removal ofthe endothelium was confirmed by scanning electron microscopy (vide infra). Individual aortic rings were placed in Petri dishes containing 1.2 ml Dulbecco's modified Eagle's medium (DME) supplemented with 100 ,ug/ml streptomycin and 100 U/ml penicillin, 1% fetal calf serum (FCS) and variously treated with indomethacin (50 MM), dexamethasone (0.1 or 1.0 MM), actinomycin D (25 MM), cycloheximide (50 WM), or their vehicles. Endotoxin was diluted from a stock preparation (1 mg/ml in DME, aliquotted and stored at -80'C), into DME. The endotoxin preparation was sonicated for 3 min at maximum power in a cup horn sonicator (Heat Systems-Ultrasonics, Inc., Plainview, NY) and dispensed into the incubation media at final concentrations of 1-100 ng/ml. The media and rings were rotated gently for 16 h in an incubator at 370C under a 95% 02-5% CO2 atmosphere.
Measurement of aortic ring contraction. After incubation, rings were mounted between two stainless steel hooks in 10-ml jacketed tissue baths. One hook was fixed in the bath and the other hook attached to a strain guage (Kulite Semiconductor, Ridgefield, NJ) for measures of ring tension. Contractions by eight rings were measured simultaneously and recorded on multichannel strip chart recorders. The rings were maintained in Krebs-Ringer bicarbonate buffer (KRB; millimolar composition: NaCl 118; KCI 4.7; CaCI2 1.3; MgSO4.7H2O 1.2; KH2PO4 1.2; NaHCO3 25.0; glucose 11.7) at pH 7.4 while being continually bubbled with 95% 02-5% CO2. The rings were stretched to a resting tension of 2.4 g and allowed to equilibrate for 30 min. The rings were then contracted by two applications of NE (0.1 MM); acetylcholine (1 MM) was added to the baths at maximal contraction to the first dose of NE to test for the functional integrity of the vascular endothelium (16) . The tissue baths were flushed with fresh KRB between applications of NE until ring tension returned to resting values. Ring contractions were then induced by stepwise cumulative additions of NE (l0-9 to 3 X I0-`M) or by sequentially adding KCI to the bath (10-90 mM); in some experiments phorbol 12,13-dibutyrate (PDB; 1 MM) was added to the baths after maximal contraction to NE was attained and any additional increments in tension recorded. All rings were blotted and weighed after experiments were completed.
Vascular cytokine release and assays. Rat aortic rings were prepared and incubated in DME supplemented with antibiotics, anti-inflammatory agents and endotoxin as described above, with the exception that incubation volumes were doubled; therefore two rings were allocated into each 2.4 ml of medium. After 16 h of incubation, the rings were removed and weighed, and the conditioned medium was desalted (Econo-Pac IODG, Bio-Rad Laboratories, Richmond, CA) and lyophilized. The lyophilized samples were redissolved in RPMI 1640 and cytokine activities measured. IL-l was measured with a mouse thymocyte comitogenic assay as described elsewhere (5) . Sample activities were compared to those of human recombinant IL-1a utilized as a standard in this assay. The sensitivity ofthis bioassay had a range of 3-6 pg/ml. TNF activity was measured by an in vitro cell cytotoxicity assay utilizing actinomycin D-treated murine fibroblast L929 cells (American Type Culture Collection, Rockville, MD). L929 cells were plated into 96-well microtiter plates at 50,000 cells per well and incubated 24 h at 370C in 5% CO2. After incubation, the medium was aspirated and 100 Ml of fresh medium was added to all wells. Recombinant human TNFa was diluted into medium for standards. 50 Ml of standards or samples plus an additional 50 Ml of medium were pipetted in duplicate into the first column of wells and then serially diluted across the plate. 100 Ml of medium containing 10 Mg/mi actinomycin D was added to all wells and the cells incubated 24 h. Cytotoxicity was detected by a tetrazolium dye technique (17) . The plates were read at 570 nM on a microtiter plate reader (model 650, Dynatech Laboratories, Inc., Alexandria, VA) against n-propyl alcohol blanks. TNF activity was quantitated by an area under the curve method as described by Hewlett et al. (18) . The sensitivity of this bioassay had a range of 100-200 pg/ml.
Measures ofprotein synthesis. 12 aortic rings (1.7 mm in length) were prepared from each rat aorta and incubated in DME supplemented with antibiotics, anti-inflammatory agents, and endotoxin as described above. After 16 h of incubation, rings were rinsed twice in PBS and transferred to RPMI 1640 that was deficient in L-methionine and L-cytine and supplemented as described above. The medium also contained 10 uCi/ml of mixed "S-labeled methionine and cysteine. The rings were incubated for an additional 2 h, rinsed twice in PBS, and frozen until processed. The rings were powdered under liquid N2, dissolved in lysis buffer (1% sodium deoxycholate, 1% Nonidet NP rings expressed elevated EC0 values (Table I) . Adding PDB to the organ baths after the maximum contraction to NE was attained returned endotoxin-treated ring contractions to normal ( Fig. 1, right panel) . Rings incubated with endotoxin also exhibited an impaired contraction to KC1 (Fig. 2) . The presence or absence of FCS in the medium during incubation did not alter the negative actions of endotoxin on aortic ring contraction to NE (data not shown).
Removal of the vascular endothelium before incubation with endotoxin improved sensitivity and maximal response to NE in comparison to endotoxin-treated rings with an intact endothelium (Fig. 3, Table I ). However, E,, and EC50 of endotoxin treated deendothelialized rings remained significantly impaired in comparison to endothelium-intact or deendothelialized control rings (Fig. 3, Table I ). Successful removal of the endothelium of the aortic rings was confirmed by the absence of vasodilatory responses to acetylcholine and by scanning electron microscopy (Fig. 4) .
Altered influence of endotoxin on aortic ring contraction after coincubation with anti-inflammatory agents and inhibitors ofprotein synthesis. Aortic rings incubated with endotoxin and dexamethasone or indomethacin exhibited a significant improvement in sensitivity and maximal contraction to NE compared to rings incubated only with endotoxin ( Fig. 5 , Table I suited in completely normal contractile responses to NE (data not shown). Incubation ofaortic rings for 16 h with actinomycin D resulted in a significant decrease in incorporation of label into protein (Table II) . The presence or absence of endotoxin, dexamethasone, indomethacin, or their vehicles had no significant effect on gross protein synthesis (Table II) .
Effect ofendotoxin on vascular cytokine release. Liberation of IL-I by aortic rings was positively correlated with exposure to endotoxin. Removal ofthe endothelium prior to incubation with endotoxin yielded a small, nonsignificant, reduction in IL-I release. Dexamethasone, indomethacin, and actinomycin D all significantly reduced endotoxin-stimulated release of IL-I (Table III) . Aortic rings released TNF in response to endotoxin in a dose-dependent fashion. In contrast to endotoxin-stimulated IL-I release from deendothelialized rings, removal of the endothelium before incubation with endotoxin halted release of TNF. Another contrast with the pattern of endotoxin-stimulated release of IL-I was that indomethacin treatment did not suppress the liberation of TNF by endotoxin-treated rings. Dexamethasone and actinomycin D significantly reduced endotoxin-stimulated release of TNF (Table III) .
Discussion
Incubation of rat aortic tissue with pathophysiologically relevant concentrations of endotoxin for an extended time resulted in major impairments in tissue response to a1-adrenoceptor-mediated and non-receptor-mediated pressor agents. It is unlikely that the impaired contraction to NE and KCl simply reflects a toxic effect of endotoxin on vascular cell energy metabolism or contractile elements because the rings can be forced to exhibit normal magnitudes of contraction when exposed to two pressor agents together, i.e., NE and PDB (Figs. 1  and 6 ). al-Adrenoceptors act via the hydrolysis of phosphatidylinositol 4,5-bisphosphate into two compounds that possess second messenger activity. Inositol trisphosphate mobilizes intracellular calcium, and diacylglycerol activates protein kinase C (PKC) to phosphorylate proteins (see Berridge [22] for review). PDB can substitute for diacylglycerol to activate PKC (23) and cause vascular contraction by a mechanism that is not completely understood (see Rasmussen et al. [24] for review). Chiu et al. (25) demonstrated that a portion of PDB-induced contraction in the rat aorta is independent of activation of the calcium-calmodulin pathway. These observations suggest that simultaneous input of stimuli that activate different avenues leading to contraction allow tissue that has been incubated with endotoxin to overcome a relatively specific lesion in the contraction mechanism.
The proximate cause of the sepsis or endotoxin-induced diminution in vascular contractile performance is not known. It is likely that impaired calcium availability to the contractile mechanism or an inability to efficiently utilize calcium contributes to the dysfunction. The importance of Ca2" availability during sepsis or after exposure to endotoxin is demonstrated by improvements in vascular contractility that occur after enhanced access to Ca2'. A subset of patients with bacterial sepsis develop both hypocalcemia and hypotension; these patients exhibited a restoration of normal blood pressure after augmentation oftheir ionized serum calcium by calcium infusion (26) . Stimulation of vascular potential-operated calcium channels by the calcium channel agonist BAY k 8644 promoted a rapid recovery in the mean arterial blood pressure of endotoxin-shocked rats (27) . In aortas isolated from endotoxin-injected rats, changing the tissue bath Ca2+ concentration from 2.5 to 7.5 mM during KCl-induced contraction resulted in normal contraction by tissue that previously manifested diminished contractile performance (28) .
Tissue incubated with endotoxin exhibits rightward-shifted and suppressed dose-response curves during stimulation with NE that are similar to the pattern observed after irreversible blockade of catecholamine receptors in the rabbit aorta (29) . Indeed, alpha, receptor number is reduced in aortas isolated from septic rats (30) , and aortic rings from septic rats exhibit reduced 45Ca2+ influx when stimulated by NE (31) . The diminished calcium influx via receptor operated calcium channels may contribute to impaired contraction in response to receptor agonists such as NE. However, diminished vascular contraction in response to KCl stimulation implies that a significant portion ofthe contractile defect resides at mechanisms other than those engaged by aI-adrenoceptor activation. This conclusion is based on the fact that KCl-induced contractions in the rat aorta are mediated by Ca2+ influx subsequent to membrane depolarization, and not by phosphoinositide hydrolysis (32) . The defect in KCl-induced contraction cannot be attributed to an impaired Ca2+ influx through potential operated calcium channels. Aortas from septic rats showed normal calcium influx during stimulation by KCl (31) . Aortas from endotoxin-injected rats exhibited 45Ca2" uptake that was greater than that of control tissue (28) ; this observation led the authors to suggest that a disturbance of intracellular calcium utilization rather than defects in potential operated calcium channels cause diminished blood vessel contractility.
Vascular endothelial and smooth muscle cells have the capacity to synthesize and release biologically active IL-I in response to endotoxin (33, 34) . In this study, the release of IL-1 by aortic rings in response to endotoxin was monitored because we have documented that IL-1 is a potent suppressor of vascular reactivity to pressor agents (5, 14, 15 thymocytes (37); therefore it is possible that rat endotheliumderived IL-6 could be measured as IL-I activity. It is unlikely that a major IL-6 influence on the thymocyte assay contributed to the measured IL-I activity in the current experiments because deendothelialized rings exhibited no significant decline in release of IL-l activity during exposure to endotoxin (Table III ). An-additional attribute of the bioassays is that IL-I and TNF can mutually interfere with assays for the other. IL-1 is cytocidal against some strains of L929 cells (38) , and TNF can augment thymocyte proliferation in the presence of phytohemagglutinin (39). However, these interactions require IL-1 and TNF concentrations greater than those measured in the current experiments (38) (39) (40) . Therefore, the values in Table III (Fig. 1, Table III) ; when endotoxin-treated rings were simultaneously treated with modulators of IL-1 synthesis (indomethacin, dexamethasone, actinomycin D) they manifested improved reactivity to NE and reciprocal changes in the release of IL-l activity (Figs. 5 and 6, Table III rings is unknown. It is possible that the difference in responses could relate to attributes of the aortic ring preparation because the rings consist of a composite of endothelial and smooth muscle cells in comparison to a preparation that consists of multiply passaged endothelial cells. Alternatively, the difference could reflect differences in stimuli (endotoxin vs. IL-1), or species or tissue examined. The observations from this study suggest that products of cyclooxygenase transduce a (42) . Dexamethasone also inhibits prostanoid synthesis via suppression of transcription of mRNA for cyclooxygenase (43) . Because products of cyclooxygenase action are necessary for the expression of at least a part of the endotoxin-induced vascular suppression and release of IL-i activity, interference with cyclooxygenase synthesis by treatment with dexamethasone could simultaneously diminish the influence of endotoxin on vascular contraction and IL-1 release. Indomethacin and dexamethasone may counter endotoxin action via the same mechanism, because endotoxin-induced suppression ofaortic reactivity to NE is not inhibited by the agents in an additive fashion (Fig. 5) .
The rat aorta releases TNF in response to endotoxin. The source of the TNF is apparently the endothelial cells, because deendothelialized rings do not exhibit enhanced release of TNF in the presence ofendotoxin (Table III) . Others (44) have shown that vascular smooth muscle cells have the capability of releasing TNF, but only under a superinduction protocol. It is unlikely that TNF directly mediates endotoxin-induced vascular contractile suppression because endotoxin causes suppression in deendothelialized rings despite the absence of TNF (Fig. 3, Table III ). In addition, incubation of rings with indomethacin partially ameliorates endotoxin-induced vascular suppression in the absence of any significant decrease in TNF release (Fig. 5 During prolonged exposure to endotoxin it may, unfortunately, be possible to overcompensate. A retrospective exami-nation of records from patients with septic shock indicated that those that died had less capability to augment peripheral vascular resistance than did survivors (2) . Numerous studies of animal models for endotoxin and septic shock and clinical observation of patients suggest that diminished systemic vascular resistance, to which diminished catecholamine reactivity would contribute, is deleterious to adequate tissue perfusion and oxygen delivery. Schumacker and Samsel (52) suggested that tissue in which microvascular perfusion defects occur may be particularly susceptible to hypoxic hypoxia. Altered distribution of cardiac output between organs occurs in sepsis and results in compromised blood flow to discrete organs (53) . Maldistribution of cardiac output between organs or within tissues, or the action of both distributive disorders in concert, could result in diminished effective perfusion of organs as has been described in an animal model for sepsis (54).
In conclusion, prolonged exposure of rat aortas to low levels of endotoxin results in diminished reactivity to NE and KC1. The action of endotoxin on the aorta is direct, because potential blood-borne mediators are not necessary. Suppression ofthe rat aorta by endotoxin does not require the presence of an intact endothelium. The efficacy of pharmacologic intervention against endotoxin-induced vascular suppression implies that the action ofendotoxin itselfis mediated by mechanisms that require de novo protein synthesis, and to a lesser extent, by products of cyclooxygenase activity. An association between the endotoxin-stimulated vascular release ofIL-1 and the extent of impaired contraction to catecholamines is present, and may reflect a vasomodulatory action for this cytokine.
